Market Overview

Trade RMED stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
8/13/19Piper JaffrayDowngradesOverweightNeutral1.5
10/22/18PiperJaffrayInitiates Coverage OnOverweight23.0
10/22/18Cantor FitzgeraldInitiates Coverage OnOverweight21.0
Show more Loading articles...

Earnings View Earnings

Q1 2019 EST Actual Surprise
EPS: -0.380 -1.160 -0.7800
Rev: 1.23M 1.75M 518.00K
Q2 2019 EST Actual Surprise
EPS: -0.980 Expected
2019-09-26
Rev: 2.06M
Fastest Market News Application
You'll Hear It First On Pro

Company Profile

Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo